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Abstract
Humanin (HN) is a 24-amino acid peptide with cytoprotective action in several cell types such as neurons and testicular
germ cells. Rattin (HNr), a homologous peptide of HN expressed in several adult rat tissues, also has antiapoptotic action. In
the present work, we demonstrated by immunocytochemical analysis and flow cytometry the expression of HNr in the
anterior pituitary of female and male adult rats as well as in pituitary tumor GH3 cells. HNr was localized in lactotropes and
somatotropes. The expression of HNr was lower in females than in males, and was inhibited by estrogens in pituitary cells
from both ovariectomized female and orquidectomized male rats. However, the expression of HNr in pituitary tumor cells
was not regulated by estrogens. We also evaluated HN action on the proapoptotic effect of TNF-a in anterior pituitary cells
assessed by the TUNEL method. HN (5 mM) per se did not modify basal apoptosis of anterior pituitary cells but completely
blocked the proapoptotic effect of TNF-a in total anterior pituitary cells, lactotropes and somatotropes from both female
and male rats. Also, HN inhibited the apoptotic effect of TNF-a on pituitary tumor cells. In summary, our results demonstrate
that HNr is present in the anterior pituitary gland, its expression showing sexual dimorphism, which suggests that gonadal
steroids may be involved in the regulation of HNr expression in this gland. Antiapoptotic action of HN in anterior pituitary
cells suggests that this peptide could be involved in the homeostasis of this gland. HNr is present and functional in GH3
cells, but it lacks regulation by estrogens, suggesting that HN could participate in the pathogenesis of pituitary tumors.
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Introduction
Humanin (HN) is a 24-amino acid peptide originally isolated
from a cDNA library of surviving neurons of familial Alzheimer’s
disease [1]. The homologous rat gene encodes a 38 aminoacid
peptide referred to as rattin (HNr). HN and HNr share aminoacid
residues essential for homodimerization, secretion and neuropro-
tection [2,3,4]. The origin of HN family peptides is controversial,
hypotheses being that they may be encoded in either the
mitochondrial or nuclear DNA [4,5,6]. HN is expressed in the
endothelial cell layer of human arteries and veins [7] and in
carotid atherosclerotic plaques [8]. HN has also been detected in
human skeletal muscle [9], plasma [10], testis and sperm [11].
HNr was shown to be expressed in a number of adult rat tissues
such as cerebral cortex, hippocampus, heart, testis and uterus,
among others [12]. So far, HNr expression in the rat pituitary has
not yet been explored.
The regulatory mechanisms of HN biosynthesis remain largely
unknown. Interestingly, HN concentration in plasma of both
humans and mice as well as HNr concentration in the rat
hypothalamus were shown to decrease with age [7,13]. However,
in a developmental expression pattern of HNr observed in rat
testis, HNr increased with age [14]. Also, HN release from
neurons increases when the cytoplasmic levels of cAMP and
calcium rise [15]. In addition, insulin-like growth factor-binding
protein-3 (IGFBP-3) interacts with HN, regulating its circulating
levels [6,16,17,18].
Many studies have demonstrated that HN suppresses cell death
induced by various Alzheimer disease-related insults [15] and by
some other injuries including serum deprivation [4]. The
cytoprotective effects of HN have been described in different cell
types including neurons [1], lymphocytes [19], pancreatic b cells
[20], testicular germ cells and Leydig cells [14,16,20].
Rate of proliferation and cell death control the number of cells
in tissues. Alterations in signaling pathways that regulate apoptosis
are involved in various pathological processes, including tumor
development. In the anterior pituitary, lactotropes and somato-
tropes exhibit the highest rate of cell renewal followed by
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corticotropes, gonadotropes and thyrotropes [21]. In male rats,
approximately 1.5% of anterior pituitary cells proliferate every
24 h, while the percentage of proliferating cells in female rats
doubles that in males. In rodents, the anterior pituitary undergoes
proliferation and apoptosis processes during the estrous cycle that
are associated with cyclic changes in the circulating levels of
gonadal steroids [21]. In lactotropes and somatotropes, apoptosis
is estrogen-dependent and occurs predominantly at proestrus,
when circulating estrogen levels are the highest [22]. Estrogen
induces a rapid apoptotic response in these cells by binding to
estrogen receptor-a associated with the plasma membrane [23].
The aim of the present study was to evaluate the expression and
action of HN peptides in anterior pituitary cells. We explored HNr
expression in the anterior pituitary of female and male rats and in
the somatolactotrope GH3 cell line, as well as modulation of this
expression by gonadal steroids. Considering that survival and
apoptosis of pituitary cells are regulated by the hormonal milieu,
we evaluated the effect of HN on TNF-a-induced apoptosis of
anterior pituitary cells from both gonadectomized female and male
rats incubated in the presence of gonadal steroids.
Our results indicate that HN exerted antiapoptotic action on
anterior pituitary cells from female and male rats and that gonadal
steroids regulated HNr expression, suggesting that HN could be
involved in tissue homeostasis in this gland. Our data also show
that HN protected GH3 cells from apoptosis whereas HNr




Adult Wistar female and male rats were kept in accordance with
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals. Rats were gonadectomized under ketamine
(100 mg/Kg, i.p.) and xylazine (10 mg/Kg, i.p.) anesthesia and
ketoprofen (5 mg/kg) for analgesia. Animals were euthanized by
decapitation. Animal protocols were previously approved by the
Ethics Committee of the School of Medicine, University of Buenos
Aires (Res. Nu 2742/2013).
Drugs
All drugs and reagents were obtained from Sigma Chemical Co.
(St. Louis, MO) except for phenol red-free Dulbecco’s modified
Eagle’s medium and supplements (GIBCO, Invitrogen, Carlsbad,
CA), FBS (GBO, Buenos Aires, Argentina), all terminal deox-
ynucleotidyltransferase-mediated dUTP nick end-labeling (TU-
NEL) reagents (Roche Molecular Biochemicals, Mannheim,
Germany), antibodies against anterior pituitary hormones (Dr.
A. Parlow, National Hormone and Pituitary Program, Torrance,
CA), anti-guinea pig rhodamine-conjugated secondary antibody
(Chemicon International, Temecula, CA), anti-rabbit IgG fluo-
rescein-conjugated secondary antibody (Vector Laboratories,
Burlingame, CA), anti-guinea pig Alexa 555-conjugated antibody
(Invitrogen, Carlsbad, CA), Humanin peptide (Genemed Synthe-
sis, Inc, San Antonio, TX) and the materials indicated below.
Animals
Adult Wistar female and male rats (200–250 g) were kept in
controlled conditions of light (12:12 h light-dark cycles) and
temperature (20–22uC). Rats were fed standard laboratory chow
and water ad libitum. Rats were ovariectomized (OVX),
orquidectomized (GNX) or sham-operated two weeks before
experiments. Anterior pituitary glands were removed within
minutes after decapitation.
Cell culture
A pool of anterior pituitary cells from 2–4 OVX or GNX rats
was used for each culture. Anterior pituitary glands were washed
several times with Dulbecco’s Modified Eagle’s Medium (D-MEM)
supplemented with 10 ml/ml MEM amino acids, 2 mM gluta-
mine, 5.6 mg/ml amphotericin B, 100 mg/ml streptomycin
(DMEM-S) and 3 mg/ml bovine serum albumin (BSA). Then,
glands were cut into small fragments. Sliced fragments were
dispersed enzymatically by successive incubations in DMEM-S-
BSA, containing 0.75% trypsin, 10% fetal bovine serum (FBS)
previously treated with 0.025% dextran-0.25% charcoal (FBS-
DCC) to remove steroids and 45 U/ml deoxyribonuclease type I
(Invitrogen). Finally, cells were dispersed by extrusion through a
Pasteur pipette in Krebs buffer without Ca2+ and Mg2+. Dispersed
cells were washed and resuspended in DMEM-S with 10% FBS-
DCC. GH3 cells were cultured in flasks containing DMEM
supplemented with 10 ml/ml MEM amino acids, 2 mM gluta-
mine, 0.56 mg/ml amphotericin B, 100 U/ml penicillin, 100 mg/
ml streptomycin, 5% FBS and 5% fetal horse serum. GH3 cells
were harvested with 0.025% tripsin-EDTA. Cell viability assessed
by trypan blue exclusion was over 90%. Anterior pituitary cells or
GH3 cells were seeded on cover slides in 24-well tissue culture
plates (16105 cells?ml21?well21) for TUNEL assay or in 24-well
tissue culture plates (36105 cells?ml21?well21) for flow cytometry
[fluorescence-activated cell sorter (FACS)] analysis. Cells were
cultured for 24 h in DMEM-S with 10% FBS-DCC and then
incubated for 24 h in phenol red-free, serum-free DMEM-S
supplemented with 0.1% BSA (DMEM-S-BSA 0.1%) containing
17b-estradiol (E2, 10
29 M) alone or with 1027 M ICI 182 780
(Tocris, Ellisville, MO), dihydrotestosterone (DHT, 1028 M) or the
corresponding vehicle (ethanol 1 or 10 ml/l). To determine
apoptosis, cells were further preincubated with HN (2.5–10 mM)
for 2 h before adding TNF-a (50 ng/ml) for 24 h in the same
medium with or without E2 or DHT.
Immunolocalization of HNr
The presence of HNr in pituitary sections and dispersed
anterior pituitary cells was evaluated by indirect immunofluores-
cent staining. To obtain pituitary sections, anesthetized OVX rats
were perfused through the left ventricle with cold 4% parafor-
maldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4. The glands
were quickly removed and kept in the same solution for 3 h at
4uC, then in 70% ice-cold ethanol for 24 h and embedded in
paraffin. Pituitary sections (4 mm) were deparaffinized in xylene
and rehydrated in graded ethanol. Dispersed pituitary cells seeded
on glass coverslips were fixed in 4% PFA. Sections and cells were
incubated for 1 h with anti-HNr antibody (Sigma, 1:100), washed
and incubated for 1 h with anti-rabbit IgG-fluorescein (Vector
Laboratories, 1:50). To identify lactotropes and somatotropes, cells
were incubated for 1 h with guinea pig anti-rat prolactin (PRL)
antiserum (1:2500) or guinea pig anti-rat growth hormone (GH)
antiserum (1:1500) and then with anti-guinea pig Alexa 555-
conjugated antibody (1:100) for 1 h. Finally, slides were mounted
with mounting medium for fluorescence (Vectashield, Vector
Laboratories) containing 49,6-diamidino-2-phenylindole, DAPI).
Control slides were incubated with the corresponding normal
serum or IgG subtype instead of primary antibody. Cells were
visualized in a fluorescence light microscope (Axiophot, Carl Zeiss,
Jena, Germany).
Expression of HNr by flow cytometry
Cultured GH3 or anterior pituitary cells from OVX and GNX
rats as well as dispersed pituitary cells from male and female rats
were harvested with 0.025% trypsin-EDTA and washed in cold
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PBS. Cells were fixed with 0.1% PFA and then permeabilized with
0.1% saponin (MP Biomedicals, Solon, OH) for 10 min in the
dark at RT. Next, cells were incubated with rabbit HNr antibody
(1 mg/ml, Sigma) in PBS-0.05% saponin for 1 h at 37uC. Then,
cells were washed and incubated with an anti-rabbit IgG antibody
conjugated with fluorescein (1:50, Vector Laboratories) in PBS-
0.05% saponin for another 1 h at 37uC. Finally, cells were washed,
resuspended in PBS and analyzed by flow cytometry (FACS) using
a FACScan (Becton Dickinson, NJ, USA). Data analysis was
performed using WinMDI 98 software. Cells were incubated with
isotype control instead of primary antibody to determine the cut-
off for HNr fluorescence.
Microscopic detection of DNA fragmentation by TUNEL
After incubation with HN, cells were fixed in 4% PFA in PBS
and permeabilized by microwave irradiation. DNA strand breaks
were labeled with digoxigenin-dUTP using terminal deoxynucleo-
tidyl transferase (Roche Molecular Biochemicals). To identify
lactotropes and somatotropes, cells were incubated for 1 h with
guinea pig anti-rat PRL antiserum (1:2500) or guinea pig anti-rat
GH antiserum (1:1500). Next, slides were incubated with
antidigoxigenin-fluorescein-conjugated antibody (1:10) to detect
incorporation of nucleotides in the 39-OH end of damaged DNA
and rhodamine-conjugated antiguinea pig secondary antibody
(1:200) in the same buffer. Slides were mounted with mounting
medium for fluorescence (Vectashield with DAPI) for DNA
staining and visualized in a fluorescence light microscope. The
percentage of apoptotic anterior pituitary cells was calculated as
[(TUNEL+)/total cells]6100, the percentage of apoptotic lacto-
tropes as [(TUNEL+ PRL+)/total PRL+ cells]6100, and the
percentage of apoptotic somatotropes as [(TUNEL+ GH+)/total
GH+ cells]6100.
Statistical analysis
The number of apoptotic cells evaluated by TUNEL was
analyzed in duplicate slides from at least two independent
Figure 1. Expression of HNr in the anterior pituitary gland. (A) Anterior pituitary sections and (B) cultured anterior pituitary cells from OVX
rats were processed for identification of HNr and pituitary hormones by double immunofluorescence. Left panels: nuclear staining with DAPI; middle
panels: immunocytochemistry for HNr; right panels: immunocytochemistry for prolactin (PRL) or growth hormone (GH). Arrows show a lactotrope and
a somatotrope expressing HNr. Scale bars: 10 mm.
doi:10.1371/journal.pone.0111548.g001
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experiments. Total cell number in each coverslip was evaluated by
DAPI nuclear staining. Results were expressed as the percentage
of TUNEL-positive cells, lactotropes or somatotropes 695%
confidence limits (CL) of the total number of cells counted in each
specific condition. Differences between proportions were analyzed
by the x2 test. Differences in the percentage of HNr-positive cells
and the mean of HNr fluorescence intensity per cell (Gmean)
between groups was analyzed by Student’s t test or two-way
ANOVA followed by planned comparisons. P,0.05 was consid-
ered significant. All experiments were performed at least twice.
Results
Pattern of HNr expression in anterior pituitary cells from
male and female rats
We first explored the expression of HNr in rat pituitary gland
sections and primary culture by immunocytochemistry. HNr was
present in the cytoplasm of a large number of anterior pituitary
cells, localized in lactotropes and somatotropes (Fig. 1). We then
compared rates of HNr expression in male and female anterior
pituitary cells. As determined by FACS, both the percentage of
anterior pituitary cells expressing HNr and the mean of HNr
fluorescence intensity per cell (Gmean) was lower in females than
in males (Fig. 2).
Estrogens decreased HNr expression in anterior pituitary
cells
To evaluate whether estrogens regulate the expression of HNr
in the female pituitary, we assessed by FACS HNr expression in
anterior pituitary cells from SHAM-operated and OVX rats.
Although ovariectomy did not modify the number of HNr-positive
anterior pituitary cells, it increased HNr Gmean in these cells
(Fig. 3), suggesting that gonadal hormones decrease HNr expres-
sion in anterior pituitary cells. To explore this possibility, anterior
pituitary cells from OVX rats were incubated with 17b-estradiol
(1029 M). Estrogens decreased the percentage of HNr-positive
cells and HNr Gmean in anterior pituitary cells (Fig. 4). The
inhibitory effect of estrogens on HNr expression was not observed
in the presence of the pure antagonist of estrogen receptors, ICI
182 780 (Fig. S1). However, in male rats, gonadectomy did not
affect HNr expression in the anterior pituitary (Fig. S2). While
DHT (1028 M) had no effect on HNr expression in anterior
pituitary cells from GNX rats, E2 inhibited its expression as we
observed in female anterior pituitary cells (Fig. 5).
HN blocked TNF-a-induced apoptosis of anterior
pituitary cells
We have previously reported that TNF-a induces apoptosis of
anterior pituitary cells, especially lactotropes and somatotropes, in
an estrogen-dependent manner [24,25]. Since HN family peptides
have been involved in the regulation of apoptosis, we explored
Figure 2. Anterior pituitary HNr expression in female rats is lower than in males. Dispersed anterior pituitary cells from intact male and
female rats were immunostained for HNr and analyzed by flow cytometry. Each column represents the mean6 SE (n = 4 animals per group) of (A) the
percentage of HNr-positive cells, and (B) the fluorescence intensity of HNr staining (Gmean). The upper panels show representative dot plots and
histograms of HNr expression in anterior pituitary cells from male and female rats. **p,0.01, Student’s t test.
doi:10.1371/journal.pone.0111548.g002
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whether HN modulates the propaoptotic effect of TNF-a in
anterior pituitary cells. For this purpose, cultured anterior pituitary
cells were incubated with TNF-a in presence of HN. The
percentage of apoptotic cells was determined by TUNEL assay
and lactotropes and somatotropes were identified by immunoflu-
orescence. HN (2.5–10 mM) per se did not modify basal apoptosis
of anterior pituitary cells (Fig. 6A–C). HN (2.5 mM) did not
modify the proapoptotic action of TNF-a on anterior pituitary
cells from OVX rats but at 5 and 10 mM concentrations abolished
TNF-a-induced apoptosis and therefore 5 mM was the concen-
tration chosen for all the following experiments. HN completely
blocked as well the proapoptotic effect of TNF-a in lactotropes
and somatotropes from OVX rats (Fig. 6D, E). HN exerted a
similar antiapoptotic effect on total anterior pituitary cells,
lactotropes and somatotropes from GNX male rats (Fig. 7A–C).
Expression and action of HN family peptides in pituitary
tumor cells
To explore whether HN plays a role in the apoptotic response of
tumor pituitary cells we investigated HNr expression and HN
activity in GH3 cells. FACS analysis of HNr expression revealed
the presence of HNr in GH3 pituitary tumor cell line. 17b-
estradiol (1029 M) did not significantly affect the percentage of
GH3 cells expressing HNr or HNr Gmean (Fig. S3). HN did not
affect the basal percentage of TUNEL-positive GH3 cells but
inhibited the apoptotic effect of TNF-a on GH3 cells (Fig. 8).
Discussion
This study demonstrates for the first time that the HNr protein
is present in the anterior pituitary gland, its expression showing
sexual dimorphism. Our results also demonstrate that HN exerts
antiapoptotic action on anterior pituitary cells, suggesting that this
peptide could be involved in the homeostasis of this gland. The
anterior pituitary gland undergoes considerable remodeling in
several physiological conditions such as pregnancy, lactation and
estrous cycle [21,22]. Of the pituitary subpopulations, lactotropes
and somatotropes have the highest cell turnover followed by
corticotropes and gonadotropes [21]. We observed that HNr is
expressed in both lactotropes and somatotropes, suggesting that
HNr could participate in the regulation of cell renewal of these
pituitary subpopulations.
Some studies have shown that the HN family peptides are
present in hormone-dependent tissues such as testis [11,14] and
uterus [26]. Now, we detected HNr expression in anterior
pituitary gland from both male and female rats. Little is known
about regulatory mechanisms of HNr synthesis. It has been
reported that HN content in plasma and hypothalamus decreases
with age [7,13]. Our study demonstrated that HNr expression in
the anterior pituitary gland was lower in females than in males,
suggesting that gonadal steroids are involved in the regulation of
HNr expression in this gland. This difference in HNr expression
could result from an inhibitory action of estrogens or, alternatively,
from a stimulatory effect of androgens. We observed that
ovariectomy increased HNr expression in the anterior pituitary
Figure 3. Ovariectomy increases anterior pituitary HNr expression. Dispersed anterior pituitary cells from SHAM and OVX rats were
immunostained for HNr and analyzed by flow cytometry. Each column represents the mean 6 SE (n = 4 animals per group) of (A) the percentage of
HNr-positive cells, and (B) the fluorescence intensity of HNr staining (Gmean). The upper panels show representative dot plots and histograms of HNr
expression in anterior pituitary cells from SHAM and OVX rats. *p,0.05, Student’s t test.
doi:10.1371/journal.pone.0111548.g003
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gland, suggesting that ovarian steroids exert an inhibitory effect on
HNr expression. In fact, in vitro estradiol decreased HNr
expression in anterior pituitary cells from gonadectomized female
and male rats, supporting the idea that estrogens are involved in
the modulation of HNr expression in vivo, exerting direct
inhibitory action. Estrogens are crucial determinants in the
regulation of anterior pituitary function and maintenance of tissue
homeostasis [27]. The changing pattern of circulating levels of
estrogens during the estrous cycle modulates both anterior
pituitary cell proliferation and death probably by modifying their
sensitivity to proliferative and proapoptotic signals [28]. There-
fore, inhibition of HNr expression by estradiol may have
consequences on anterior pituitary cell turnover. Also, a fall of
circulating in estrogen levels, and consequently a lack of estrogen
feedback on the hypothalamus, can stimulate hypothalamic
GnRH release, which was reported to increase HNr expression
in immature rat testis [29]. Although it was not examined in the
present study, inhibitory action of estrogens on HNr expression
could possibly be exerted in other tissues.
A number of studies have demonstrated that HN suppresses cell
death in neurons exposed to several insults such as b-amyloid
[1,30], oxidative stress [31,32], serum deprivation [19] and
hypoxia [33]. HN also has cytoprotective action in several cell
types such as pancreatic b cells [20], lymphocytes [19] and
testicular germ cells [16]. We previously reported that estradiol
induces apoptosis of anterior pituitary cells from OVX rats not
only by sensitizing them to proapoptotic stimuli such as dopamine
[34], prolactin [35], TNF-a [36] and FasL [37] but also by direct
proapoptotic action on lactotropes and somatotropes [38]. Our
study demonstrated that HN prevented apoptosis caused by TNF-
a in anterior pituitary cells, especially in lactotropes and
somatotropes from both gonadectomized female and male rats.
The expression of HNr in lactotropes and somatotropes and the
antiapoptotic action of HN suggests a role of HNr in regulation of
cell turnover of these pituitary subpopulations. Our results also
showed that HNr is present and functional in GH3 cells,
suggesting that HN could participate in the pathogenesis of
pituitary tumors. Interestingly, the estrogenic modulation of HNr
expression is absent in this tumor cell line.
HN has been shown to interact with two classes of receptors. It
binds to the formylpeptide receptor-like-1 (FPRL-1) receptor [39],
and also to a receptor complex with three subunits consisting of
WSX-1 (IL-27 receptor), ciliary neurotrophic factor receptor a
(CNTFR), and glycoprotein 130 (gp130), a subunit of interleukin-6
receptor [40,41]. After binding to its specific receptor, HN
mediates its protective effect through activation of STAT3 [42],
JNK [43] and tyrosine kinases [42]. The three subunits described
for the putative HN receptor, WSX-1, CNTFR, and gp130 were
reported to be expressed in the anterior pituitary [44,45]. Since
HN family peptides can be released from cells [14,18], HNr could
exert its effects on anterior pituitary cells in an autocrine and/or
paracrine manner. Another antiapoptotic mechanism has also
Figure 4. Estradiol decreases HNr expression in anterior pituitary cells from OVX female rats. Cultured anterior pituitary cells from OVX
rats were incubated with 17b-estradiol (E2, 10
29 M) or vehicle (Veh, ethanol 1 ml/l) for 24 h, immunostained for HNr and analyzed by flow cytometry.
Each column represents the mean6 SE of (A) the percentage of HNr-positive cells, and (B) the fluorescence intensity of HNr staining (Gmean) from 3
independent experiments (3 replicates each one). The upper panels show representative dot plots and histograms of HNr expression in anterior
pituitary cells from OVX rats incubated with 17b-estradiol. *p,0.05, Student’s t test.
doi:10.1371/journal.pone.0111548.g004
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Figure 5. Estradiol decreases HNr expression in anterior pituitary cells from GNX male rats. Cultured anterior pituitary cells from GNX
male rats were incubated with (A) dihydrotestosterone (DHT, 1028 M) or vehicle (Veh, ethanol 10 ml/l) or (B) 17b-estradiol (E2, 1029 M) or vehicle (Veh,
ethanol 1 ml/l) for 24 h, immunostained for HNr and analyzed by flow cytometry. Each column represents the mean 6 SE of the percentage of HNr-
positive cells from 3 independent experiments (3 replicates each one). The upper panels show representative dot plots of HNr expression in anterior
pituitary cells from GNX rats incubated with dihydrotestosterone or 17b-estradiol. *p,0.05, Student’s t test.
doi:10.1371/journal.pone.0111548.g005
Figure 6. HN protects anterior pituitary cells from TNF-a-induced apoptosis in female rats. Cultured anterior pituitary cells from OVX rats
were incubated with 17b-estradiol (E2, 10
29 M) for 24 h and then with HN 2.5 mM (A), 5 mM (B), or 10 mM (C) for 2 h before adding TNF-a (50 ng/ml)
for an additional 24 h. Apoptosis was assessed by the TUNEL method. In cells incubated with 5 mM HN, apoptotic lactotropes (D) and somatotropes
(E) were identified by immunofluorescence. Each column represents the percentage 6 CL of TUNEL-positive anterior pituitary cells (A, B, C, n$1500
cells/group), lactotropes (D, n$1600 cells/group) or somatotropes (E, n$1800 cells/group). Data from at least two separate experiments were
analyzed by x2 test. *p,0.05, **p,0.01 vs respective control without TNF-a; ‘p,0.05, ‘‘p,0.01 vs respective control without HN.
doi:10.1371/journal.pone.0111548.g006
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been demonstrated by which intracellular HN interacts with
proapoptotic Bcl-2 family members such as Bax [5,29], BimEL
[46] and tBid [47], their translocation to mitochondria prevailing
and thereby inhibiting the formation of the apoptosome and
activation of caspase-3. The mechanism by which HN protects
anterior pituitary cells from proapoptotic stimuli, not examined in
the present study, remains to be determined.
Since HN was reported to be overexpressed in gastric cancer
cells and considering that HN has antiapoptotic activity in these
cells, it was suggested that HN upregulation could be an important
molecular event in tumorigenesis [48]. Apoptotic processes play an
important role in maintaining the number of cells in the pituitary
gland during different physiological events. Alterations in signaling
pathways involved in the dynamic maintenance of pituitary cell
populations have implications in tumorigenesis. Since HN exerts
antiapoptotic action in normal and tumoral anterior pituitary cells,
it is possible that changes in the expression of HN or its receptors
may affect cell turnover, playing a role in the development of
anterior pituitary tumors. Full elucidation of HN antiapoptotic
action and its role in the physiology and pathology of the anterior
pituitary gland will contribute to a better understanding of the
basic mechanisms possibly involved in the pathogenesis of pituitary
tumors.
Supporting Information
Figure S1 An estrogen receptor antagonist reverses the
inhibitory effect of estradiol on HNr expression in anterior
pituitary cells from female rats. Cultured anterior pituitary cells
from OVX rats were incubated with 17b-estradiol (E2, 10
29 M) or
vehicle (Veh, ethanol 1 ml/l) in the presence of ICI 182 780 (ICI,
1027 M) for 24 h, immunostained for HNr and analyzed by flow
cytometry. Each column represents the mean 6 SE of the
percentage of HNr-positive cells from 2 independent experiments
(4 replicates each one). **p,0.01 vs respective control without
estradiol, ‘p,0.05 vs respective control without ICI. Two-way
ANOVA followed by planned comparisons.
(TIF)
Figure S2 Gonadectomy does not modify HNr expression in
anterior pituitary from male rats. Dispersed anterior pituitary cells
from SHAM and GNX rats were immunostained for HNr and
Figure 7. HN protects anterior pituitary cells from TNF-a-
induced apoptosis in male rats. Cultured anterior pituitary cells
from GNX male rats were incubated with dihydrotestosterone (DHT,
1028 M) for 24 h and then with HN (5 mM) for 2 h before adding TNF-a
(50 ng/ml) for an additional 24 h. Apoptosis was assessed by the TUNEL
method and lactotropes and somatotropes detected by immunofluo-
rescence. Each column represents the percentage 6 CL of TUNEL-
positive anterior pituitary cells (A, n$1400 cells/group), lactotropes (B,
n$1400 cells/group) or somatotropes (C, n$1300 cells/group). Data
from at least two separate experiments were analyzed by x2 test. *p,
0.05 respective control without TNF-a; ‘p,0.05 vs respective control
without HN.
doi:10.1371/journal.pone.0111548.g007
Figure 8. HN protects GH3 cells from TNF-a-induced apoptosis.
Cultured GH3 cells were incubated with HN (5 mM) for 2 h before
adding TNF-a (50 ng/ml) for 24 h. Apoptosis was assessed by the
TUNEL method. Each column represents the percentage 6 CL of
TUNEL-positive cells (n$1000 cells/group). Data from two separate
experiments were analyzed by x2 test. **p,0.01 respective control
without TNF-a, ‘‘p,0.01 vs respective control without HN.
doi:10.1371/journal.pone.0111548.g008
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analyzed by flow cytometry. Each column represents the mean 6
SE (n= 4 animals per group) of (A) the percentage of HNr-positive
cells, and (B) the fluorescence intensity of HNr staining (Gmean).
The upper panels show representative dot plots and histograms of
HNr expression in anterior pituitary cells from SHAM and GNX
rats. NS, Student’s t test.
(TIF)
Figure S3 Estradiol does not modify HNr expression in GH3
cells. Cultured GH3 cells were incubated with 17b-estradiol (E2,
1029 M) or vehicle (Veh, ethanol 1 ml/l) for 24 h, immunostained
for HNr and analyzed by flow cytometry. Each column represents
the mean 6 SE from 3 independent experiments (3 replicates
each) of (A) the percentage of HNr-positive cells, and (B) the
fluorescence intensity of HNr staining (Gmean). The upper panels
show representative dot plots and histograms of HNr expression in
GH3 cells. NS, Student’s t test.
(TIF)
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